A. Cardiovascular Disease
A1. Cheng HM, Koutsidis G, et al. Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis. 2017 Feb;257:100-108.
A2. Song B, Liu K, et al. Lycopene and risk of cardiovascular diseases: A meta-analysis of observational studies. Mol Nutr Food Res. 2017 Sep;61(9).
B. High Blood Pressure
B1. Li X, Xu J. Lycopene supplement and blood pressure: an updated meta-analysis of intervention trials. Nutrients. 2013;5(9):3696-3712.
C. High Cholesterol
C1. Ried K, Fakler P. Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials. Maturitas. 2011 Apr;68(4):299-310.
D1. Lodi G, Franchini R, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016 Jul 29;7:CD001829.
E. Ovarian Cancer
E1. Li X, Xu J. Meta-analysis of the association between dietary lycopene intake and ovarian cancer risk in postmenopausal women. Sci Rep. 2014 May 9;4:4885.
F1. Tenório MB, Ferreira RC, et al. Oral antioxidant therapy for prevention and treatment of preeclampsia: Meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2018;28(9):865-876.
G. Prostate Cancer Prevention
G1. Ilic D, Forbes KM, et al. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev. 2011;(11):CD008007.
G2. Wang Y, Cui R, et al. Effect of Carotene and Lycopene on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Observational Studies. PLoS One. 2015 Sep 15;10(9):e0137427.
G3. Cataño JG, Trujillo CG, et al. [Efficacy of lycopene intake in primary prevention of prostate cancer: a systematic review of the literature and meta-analysis.] Arch Esp Urol. 2018;71(2):187-197.